1. Home
  2. DNOW vs XENE Comparison

DNOW vs XENE Comparison

Compare DNOW & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NOW Inc.

DNOW

NOW Inc.

HOLD

Current Price

$15.13

Market Cap

2.7B

Sector

Industrials

ML Signal

HOLD

XENE

Xenon Pharmaceuticals Inc.

HOLD

Current Price

$40.85

Market Cap

3.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DNOW
XENE
Founded
1862
1996
Country
United States
Canada
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
3.2B
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
DNOW
XENE
Price
$15.13
$40.85
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
11
Target Price
$17.33
$54.09
AVG Volume (30 Days)
2.3M
1.1M
Earning Date
02-12-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.87
N/A
Revenue
$2,432,000,000.00
$7,500,000.00
Revenue This Year
$21.37
N/A
Revenue Next Year
$92.57
N/A
P/E Ratio
$17.32
N/A
Revenue Growth
3.18
N/A
52 Week Low
$12.01
$26.74
52 Week High
$18.45
$46.60

Technical Indicators

Market Signals
Indicator
DNOW
XENE
Relative Strength Index (RSI) 66.35 43.64
Support Level $14.35 $40.81
Resistance Level $15.44 $43.70
Average True Range (ATR) 0.43 1.68
MACD 0.12 0.03
Stochastic Oscillator 82.76 35.69

Price Performance

Historical Comparison
DNOW
XENE

About DNOW NOW Inc.

Dnow Inc is a company engaged in world-wide supplying of energy and industrial products and packaged, engineered process and production equipment with a legacy of over one sixty years. It offers a broad set of supply chain solutions combined with a suite of digital solutions branded as DigitalNOW that provide customers world-class technology for digital commerce, data and information management. Its locations provide products and solutions to exploration and production companies, midstream transmission and storage companies, refineries, chemical companies, utilities, mining, municipal water, manufacturers, engineering and construction companies. The Company has three reportable segments being United States, Canada and International.

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

Share on Social Networks: